MSN Group launches Fesobig to treat urinary incontinence and overactive bladder
It is first-line therapy recommended by various international treatment guideline for overactive bladder (OAB)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Fesoterodine Fumarate
Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release…
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz Extended-Release tablets, 4 mg…